Raiffeisen Schweiz Genossenschaft, a Swiss systemically relevant bank, issued AT1 Bonds in the total amount of CHF 300 million. With a base tranche of CHF 200 million on 31 March 2021 and a first reopening of CHF 100 million on 1
Tags :Homburger
Québec issued CHF 250 million Bonds. Deutsche Bank London Branch, acting through Deutsche Bank Zurich Branch acted as Lead Manager. The Bonds will be listed on the SIX Swiss Exchange. Homburger advised Deutsche Bank Zurich
Gaz Finance issued Chf 500 m Loan Participation Notes on June 30, 2021. The Loan Participation Notes were used to fund a loan by the Issuer to Public Joint Stock Company Gazprom. UBS acted as lead manager, together
Private equity healthcare fund ArchiMed announced the acquisition of Stragen Pharma from its founder and several shareholders, through its EUR 1 billion MED Platform I fund. The advisors Walder Wyss acted as legal counsel
Hrs Real Estate submitted a building application in Arbon for the construction of a hotel with 63 rooms, a restaurant and spa and meeting facilities on the former Saurer area in Arbon, Homburger advised the investor
The City of Zurich successfully issued CHF 150 million 0.00% senior bonds due 2030. The issuance is documented in a prospectus that is fully compliant with the Financial Services Act. Homburger acted as transaction counsel with respect to
The Baugarten cooperative formerly known as Sparkasse der Stadt Zürich, a cooperative which, together with the foundation Baugarten, promotes and supports social, cultural and scientific projects and works in Switzerland, predominantly in the canton
Private equity firm, Naxicap Partners has closed the acquisition of a majority stake in Groupe 3R (Réseau Radiologique Romand), a Swiss radiological network created by Dr. Dominique Fournier. The advisors Python advised Naxicap Partners
Transocean entered into an equity distribution agreement with Jefferies. Pursuant to the terms of the agreement, Transocean may offer and sell its shares, par value CHF 0.10 per share, from time to time through Jefferies, as
Molecular Partners, a clinical-stage biotech company, announced the pricing of its Initial Public Offering of 3,000,000 American Depositary Shares (ADS) in the United States at a public offering price of USD 21.25 per ADS, for total gross
